Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Type-II diabetes preparation and preparation method thereof

A diabetes and preparation technology, applied in the field of type II diabetes preparations and their preparation, can solve the problems of ineffective control of postprandial blood sugar by insulin, cross allergy to sulfonamide drugs, damage to the liver and kidneys, etc. Utilization rate, the effect of reducing toxic and side effects

Inactive Publication Date: 2016-10-26
北京巧致达人健康科技有限公司
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] The second stage: characterized by insulin resistance and postprandial blood glucose rise, this is because the insulin secreted by β cells does not match insulin resistance or changes in the secretion pattern of β cells make insulin unable to effectively control postprandial blood glucose
[0021] At present, there are the following problems in the drug treatment of diabetes at home and abroad: biguanide drugs have large side effects; sulfonamide drugs damage the liver and kidneys, and are prone to cross allergies with sulfonamide drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Type-II diabetes preparation and preparation method thereof
  • Type-II diabetes preparation and preparation method thereof
  • Type-II diabetes preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0055] The following clearly and completely describes the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, but not all of the embodiments. The detailed descriptions of the embodiments of the invention provided below are not intended to limit the scope of the claimed invention but represent only selected embodiments of the invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts fall within the protection scope of the present invention.

[0056] The present invention aims to provide a preparation for regulating type Ⅱ diabetes, which can effectively treat diabetes, comprehensively regulate metabolic disorders, enhance the immunity of the patient through conditioning and repairing the patient's body, restore the function of pancreatic islets, promote the secretion of insulin,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a type-II diabetics preparation. The type-II diabetes preparation is prepared from the following components in parts by weight: 15 to 30 parts of black tartary buckwheat, 20 to 50 parts of dietary fiber, 10 to 25 parts of ganoderma lucidum spore powder, 1 to 8 parts of extract of mulberry fruit, and 1 to 5 parts of stachyose. The type-II diabetes preparation has the advantages that 1, by repairing and enhancing the normal metabolism function of organs on blood glucose, the effect of further preventing and treating type-II diabetes is realized; 2, cordyceps militaris which can excrete chitinase is used as micrococcus lysoleikticus, the wall of ganoderma lucidum spore can be effectively and safely broken, the active matter of ganoderma lucidum spore powder is furthest reserved and protected, and the human body can favorably absorb and utilize same; 3, a yeast cell is cultured in a trivalent chromium-containing culture medium, and the inorganic chromium is biologically converted into organic chromium, so that the absorbing and utilization rate of chromium in the human body is improved, the toxic or side effect is decreased, and the function of regulating blood glucose, lipid and cholesterol is well realized; 4, the components are simple, the production technology is simple, the production cost is low, and the type-II diabetes preparation can be widely popularized and applied.

Description

technical field [0001] The invention relates to a diabetes preparation, especially a type II diabetes preparation and a preparation method thereof. Background technique [0002] Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is caused by defective insulin secretion or impaired biological action, or both. The long-term high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves. [0003] Diabetes is divided into type 1 and type 2 diabetes: [0004] Type 1 diabetes: [0005] The age of onset is young, most of them are <30 years old, the onset is sudden, the symptoms of polydipsia, polyuria, polyphagia, and weight loss are obvious, and the blood sugar level is high. Many patients have ketoacidosis as the first symptom, low serum insulin and C-peptide levels, ICA, IAA Or GAD antibody can be positive. Oral medication alone is ineffective and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/70C07H3/06C07H1/08A61P3/10A61K31/715A61K31/702
CPCA61K36/70A61K31/702A61K31/715A61K36/064A61K36/074A61K36/605A61K2236/19A61K2236/31A61K2236/333A61K2236/35C07H1/08C07H3/06A61K2300/00
Inventor 史晓旻史云仙
Owner 北京巧致达人健康科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products